CD40 drug before surgery can benefit patients with early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T ce...
Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer
Researchers have called on European policymakers t...
First report card on biosimilars in oncology
Researchers have developed the first report card o...
Global oncology pharmacists face restricted access to essential PPE items
Oncology pharmacy practitioners around the globe a...